CD47 and breast cancer: We have previously demonstrated that the CTCs of BC patients frequently express EMT/stem-like phenotypes, and putative immune checkpoints such as CD47 and PD-L1 [26,31]; consequently our findings provide indications that these mechanisms may also cooperate on BC patients’ CTCs.